Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$34,252
in 1 filing

Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis Mark Steven −$34K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-09-30 Wenstrup Richard Chief Medical Officer Returned to the company −931 $20.58 $19K 50,207
2016-09-17 Wenstrup Richard Chief Medical Officer Returned to the company −931 $20.92 $19K 51,138
2016-09-14 Wenstrup Richard Chief Medical Officer Grant or award +30,000 52,069
2015-09-17 Wenstrup Richard Chief Medical Officer Shares withheld for taxes −931 $41.39 $39K 22,069
2015-09-15 Wenstrup Richard Chief Medical Officer Grant or award +11,500 23,000

Page 1 of 1 · 5 trades